Amylyx Pharmaceuticals Etf Price Prediction
| AMLX Etf | USD 15.01 0.75 4.76% |
Momentum 48
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.37) | EPS Estimate Current Year (1.53) | EPS Estimate Next Year (1.25) | Wall Street Target Price 20.2222 | EPS Estimate Current Quarter (0.43) |
Using Amylyx Pharmaceuticals hype-based prediction, you can estimate the value of Amylyx Pharmaceuticals from the perspective of Amylyx Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Amylyx Pharmaceuticals using Amylyx Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Amylyx using crowd psychology based on the activity and movement of Amylyx Pharmaceuticals' stock price.
Amylyx Pharmaceuticals Implied Volatility | 0.95 |
Amylyx Pharmaceuticals' implied volatility exposes the market's sentiment of Amylyx Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amylyx Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amylyx Pharmaceuticals stock will not fluctuate a lot when Amylyx Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Amylyx Pharmaceuticals to buy its etf at a price that has no basis in reality. In that case, they are not buying Amylyx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell etfs at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Amylyx Pharmaceuticals after-hype prediction price | USD 15.78 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Amylyx contract
Based on the Rule 16, the options market is currently suggesting that Amylyx Pharmaceuticals will have an average daily up or down price movement of about 0.0594% per day over the life of the 2026-03-20 option contract. With Amylyx Pharmaceuticals trading at USD 15.01, that is roughly USD 0.008912 . If you think that the market is fully incorporating Amylyx Pharmaceuticals' daily price movement you should consider acquiring Amylyx Pharmaceuticals options at the current volatility level of 0.95%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Amylyx Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Amylyx Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Amylyx Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amylyx Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of Amylyx Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Amylyx Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Amylyx Pharmaceuticals' etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amylyx Pharmaceuticals' historical news coverage. Amylyx Pharmaceuticals' after-hype downside and upside margins for the prediction period are 11.74 and 19.82, respectively. We have considered Amylyx Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Amylyx Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Amylyx Pharmaceuticals is based on 3 months time horizon.
Amylyx Pharmaceuticals Etf Price Outlook Analysis
Have you ever been surprised when a price of a ETF such as Amylyx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amylyx Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amylyx Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.15 | 4.06 | 0.01 | 0.06 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
15.01 | 15.78 | 0.13 |
|
Amylyx Pharmaceuticals Hype Timeline
Amylyx Pharmaceuticals is presently traded for 15.01. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.06. Amylyx is expected to increase in value after the next headline, with the price projected to jump to 15.78 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.13%, whereas the daily expected return is presently at 0.15%. The volatility of related hype on Amylyx Pharmaceuticals is about 1076.92%, with the expected price after the next announcement by competition of 15.07. The company reported the previous year's revenue of 87.37 M. Net Loss for the year was (301.74 M) with loss before overhead, payroll, taxes, and interest of (92.75 M). Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out Amylyx Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Amylyx Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Amylyx Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Amylyx Pharmaceuticals' future price movements. Getting to know how Amylyx Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amylyx Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ORIC | Oric Pharmaceuticals | (0.16) | 11 per month | 3.06 | (0.02) | 6.63 | (4.36) | 15.34 | |
| RLAY | Relay Therapeutics | 0.34 | 12 per month | 3.22 | 0.02 | 5.60 | (5.45) | 27.25 | |
| INBX | Inhibrx Biosciences | 0.48 | 9 per month | 4.20 | 0.11 | 7.03 | (6.08) | 112.80 | |
| SNDX | Syndax Pharmaceuticals | 0.08 | 10 per month | 2.36 | 0.10 | 8.70 | (3.59) | 18.37 | |
| NKTR | Nektar Therapeutics | 2.74 | 11 per month | 0.00 | (0.17) | 6.56 | (7.77) | 20.31 | |
| ATAI | ATAI Life Sciences | (0.01) | 8 per month | 0.00 | (0.17) | 5.77 | (5.54) | 22.95 | |
| SANA | Sana Biotechnology | (0.15) | 7 per month | 0.00 | (0.02) | 12.59 | (8.77) | 25.63 | |
| PGEN | Precigen | 0.30 | 8 per month | 4.66 | 0.06 | 8.52 | (7.08) | 38.64 | |
| CVAC | CureVac NV | 0.05 | 7 per month | 0.00 | (0.11) | 3.33 | (2.80) | 18.10 | |
| IMTX | Immatics NV | 0.1 | 8 per month | 0.00 | (0.03) | 7.31 | (6.47) | 30.34 |
Amylyx Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Amylyx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amylyx using various technical indicators. When you analyze Amylyx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Amylyx Pharmaceuticals Predictive Indicators
The successful prediction of Amylyx Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Amylyx Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Amylyx Pharmaceuticals based on analysis of Amylyx Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Amylyx Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amylyx Pharmaceuticals's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Amylyx Etf
Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.